Figure 1From: Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain Decision-tree model of posaconazole versus SAT (standard azole treatment; fluconazole or itraconazole) for the prevention of invasive fungal infection (IFI) among high-risk neutropenic patients. M = Markov model.Back to article page